Entry |
|
Name |
Belfosdil (USAN/INN) |
Formula |
C27H50O7P2
|
Exact mass |
548.3032
|
Mol weight |
548.63
|
Structure |

|
Class |
Cardiovascular agent
DG01575 Calcium channel blocker
|
Efficacy |
Antihypertensive, Calcium channel blocker |
Target |
|
Pathway |
hsa04261 | Adrenergic signaling in cardiomyocytes |
hsa04270 | Vascular smooth muscle contraction |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Cardiovascular agent
DG01575 Calcium channel blocker
D03067 Belfosdil
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Calcium channels
CACNA1-L
D03067 Belfosdil (USAN/INN)
|
Other DBs |
|
KCF data |
ATOM 36
1 C8x C 11.1300 -18.4100
2 C8x C 11.1300 -19.8100
3 C8x C 12.3424 -20.5100
4 C8x C 13.5549 -19.8100
5 C8y C 13.5549 -18.4100
6 C8x C 12.3424 -17.7100
7 O2a O 14.7924 -17.7100
8 C1b C 16.0049 -18.4100
9 C1b C 17.2173 -17.7100
10 C1c C 18.4297 -18.4100
11 C1b C 19.6422 -17.7100
12 C1b C 18.4297 -19.8099
13 P1b P 19.6274 -20.5014
14 O2b O 20.8124 -19.8100
15 C1b C 22.0249 -20.5100
16 C1b C 23.2373 -19.8100
17 C1b C 24.4497 -20.5100
18 C1a C 25.6622 -19.8100
19 O2b O 19.6307 -21.9097
20 C1b C 20.8124 -22.6100
21 C1b C 22.0249 -21.9100
22 C1b C 23.2373 -22.6100
23 C1a C 24.4497 -21.9100
24 O3b O 18.4149 -21.2014
25 P1b P 19.6423 -16.3103
26 O2b O 20.8824 -15.6100
27 C1b C 22.0949 -16.3100
28 C1b C 23.3073 -15.6100
29 C1b C 24.5197 -16.3100
30 C1a C 25.7322 -15.6100
31 O2b O 19.6423 -14.2103
32 C1b C 20.8824 -13.5100
33 C1b C 22.0949 -14.2100
34 C1b C 23.3073 -13.5100
35 C1a C 24.5197 -14.2100
36 O3b O 18.4297 -15.6100
BOND 36
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 10 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 16 17 1
18 17 18 1
19 13 19 1
20 19 20 1
21 20 21 1
22 21 22 1
23 22 23 1
24 13 24 2
25 11 25 1
26 25 26 1
27 26 27 1
28 27 28 1
29 28 29 1
30 29 30 1
31 25 31 1
32 31 32 1
33 32 33 1
34 33 34 1
35 34 35 1
36 25 36 2
|